Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a …

…, F Berghea, S Bojin, MAI Arvunescu, RM Ionescu… - The Lancet, 2017 - thelancet.com
Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the comparative …

[HTML][HTML] Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study

…, D Henrohn, K Horslev-Petersen, R Ionescu… - Arthritis research & …, 2010 - Springer
Introduction Work disability is a major consequence of rheumatoid arthritis (RA), associated
not only with traditional disease activity variables, but also more significantly with …

“To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity

…, G Riemekasten, M Cutolo, R Ionescu… - Seminars in arthritis and …, 2012 - Elsevier
OBJECTIVES: To determine if mixed connective tissue disease (MCTD) can be considered
an independent clinical entity, to compare 3 different classification criteria for MCTD (…

Quantification and molecular characterization of regulatory T cells in connective tissue diseases

…, L Banica, A Besliu, G Pistol, C Stavaru, R Ionescu… - …, 2009 - Taylor & Francis
The aim of our study was to investigate and characterize regulatory T cells (Treg) in
peripheral blood of patients with connective tissue diseases (Systemic lupus erythematosus, …

Digital ulcers predict a worse disease course in patients with systemic sclerosis

…, PI Constantin, AM Gherghe, R Ionescu… - Annals of the …, 2016 - ard.bmj.com
Objective Systemic sclerosis (SSc) is a systemic autoimmune disease with high morbidity
and significant mortality. There is a great need of predictors that would allow risk stratification …

[HTML][HTML] Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

…, N Damjanov, P Djukic, R Ionescu… - … medical journal of …, 2011 - ncbi.nlm.nih.gov
… Ewa Orlewska, 1, A, B, C, D, E, F, G Ioan Ancuta, 2, B Branimir Anic, 3, B Catalin Codrenau,
4, B Nemanja Damjanov, 5, B Predrag Djukic, 6, B Ruxandra Ionescu, 7, B Lubomir …

[HTML][HTML] COVID-19 vaccine does not increase the risk of disease flare-ups among patients with autoimmune and immune-mediated diseases

L Pinte, F Negoi, GD Ionescu, S Caraiola… - Journal of Personalized …, 2021 - mdpi.com
Background: Reports describing post-vaccine autoimmune phenomena, in previously healthy
individuals, increased the concerns regarding the risk of disease flare-ups in patients with …

[HTML][HTML] Gut microbiome changes in gestational diabetes

RF Ionescu, RM Enache, SM Cretoiu… - International Journal of …, 2022 - mdpi.com
Gestational diabetes mellitus (GDM), one of the most common endocrine pathologies during
pregnancy, is defined as any degree of glucose intolerance with onset or first discovery in …

European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire …

…, S Soldano, L Andreoli, F Dall'Ara, R Ionescu… - Autoimmunity …, 2017 - Elsevier
Objective To collect data on vitamin D (25(OH)D) serum levels in a large number of rheumatoid
arthritis (RA) patients from different European countries, to investigate their relation with …

Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc. net-project

…, J Erwin, V Fialka-Moser, R Ionescu… - Annals of the …, 2015 - ard.bmj.com
Objective The eumusc.net project is an initiative founded by the European Community and
the European League Against Rheumatism. One aim of the project was to facilitate equal …